000 01305 a2200349 4500
005 20250514041553.0
264 0 _c20021008
008 200210s 0 0 eng d
022 _a1068-9265
024 7 _a10.1007/BF02574483
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBloomston, Mark
245 0 0 _aMatrix metalloproteinases and their role in pancreatic cancer: a review of preclinical studies and clinical trials.
_h[electronic resource]
260 _bAnnals of surgical oncology
_cAug 2002
300 _a668-74 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aGene Expression Regulation, Enzymologic
650 0 4 _aHumans
650 0 4 _aHydroxamic Acids
_xtherapeutic use
650 0 4 _aMatrix Metalloproteinase Inhibitors
650 0 4 _aMatrix Metalloproteinases
_xgenetics
650 0 4 _aMice
650 0 4 _aPancreatic Neoplasms
_xenzymology
650 0 4 _aTissue Inhibitor of Metalloproteinases
_xgenetics
650 0 4 _aTransfection
700 1 _aZervos, Emmanuel E
700 1 _aRosemurgy, Alexander S
773 0 _tAnnals of surgical oncology
_gvol. 9
_gno. 7
_gp. 668-74
856 4 0 _uhttps://doi.org/10.1007/BF02574483
_zAvailable from publisher's website
999 _c12050535
_d12050535